Cardiology
Singapore wants healthcare AI that does not think like the West. Cardiometabolic care is its first real test
Singapore’s publicly funded SIMFONI programme will adapt foundation AI models using local clinical data, guidelines and workflows, beginning with cardiometabolic decision support in primary care and multimodal tools for eye disease. Localisation could make healthcare AI safer and more relevant. It could also automate local blind spots unless subgroup performance, accountability and clinical impact are…
Chronic pain may be a cardiovascular warning sign, not just a symptom
Could AI help prevent the next athlete cardiac tragedy? Evidence is moving faster than practice
Heatwaves are emerging as a cardiovascular risk factor, prompting calls for stronger climate adaptation and public health policies
Metabolic health is no longer just a clinic problem. It is a city, climate and equity problem
HEARTS 2.0: Latin America moves beyond hypertension and into cardio-kidney-metabolic care
What happens when surgeons no longer need to be in the same country as their patients?
The WHO’s first stroke resolution turns a clinical problem into a political one
The invisible heart disease crisis: Why congenital heart disease is moving up the global health agenda
A new guideline is changing how health systems think about obesity, diabetes and heart disease
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.